Whenever I post, I always select a color, but it never shows up!

I know I'm either doing something wrong, or NOT doing it at all,lol..
ALL help will be greatly appreciated, as I seem to be a bit dense,lol....

Take care and be well! Btw, I didn't select ANY color for this post,lol.

Well, well............after mentioning TZDs on another thread here with BioDoc, I thought......hey, I'll check and see what, if anything, IS coming down the pike regarding TZDs and MS. (I mentioned in the other thread where a few months ago, actually I think it was more like a year ago, I had run across a quick mention buried in a diabetes publication about TZDs and MS.)

Here's what I found today. This is anecdotal, at best, ...

I found this today and found several of the areas interesting, as I was reading a forum I saw this mentioned and it was stated it had helped the poster greatly , yet her friend with MS it did nothing for, seems like another treatment that works for some and for some it doesn't.

The post was from last week but this patent was from 95-96..

Interesting as to the anti-depressant part..

My thought on the efficacy of antibiotics is that the pathogen is stimulating a heat shock-type/stress response in the cells. When a pathogen invades a cell or tissue, the pathogen tries to set up its optimal conditions: altering the pH, changing the ionic milieu, taking over transcription machinery (polymerases), and translation machinery (ribosomes). The pathogen will replicate or go into a latent phase to replicate at a later date. The cell, on the other hand, ...

Dear all,

I have not heard much about Campath in the last months. News about Campath looked very promising only one year ago. Anybody knows anything about current research and trials ?

Thanks

Ric

Well, what can I say...I'm on a roll now! :wink:

Going back to my last thread regarding CrVI (environmental toxicity) and MS, I ended with a research article that mentioned P53 apoptosis.

Ok.....how does P53 apoptosis directly pertain to MS? Here's what I found:

J Neurochem. 2003 May;85(3):635-44. Related Articles, Links

Oligodendrocyte injury in multiple sclerosis: a role for p53.

Wosik K, Antel J, Kuhlmann T, Bruck ...

Hi, folks!

Well........I'm off today (holiday), so needless to say I'm researching again. Get this! (I stumble onto the strangest things!)

We all know of my previous and continuing research regarding the drug desipramine. So, this morning, I thought I'd check to see what new items of interest might be coming down the pike regarding desipramine. (Please stay with me here........this is another of my "here's how I put it together" scenarios.) I'll highlight, as ...

Dear all,

I was looking at the Australian MS society website and came across a presentation on research which made interesting reading. The website address for the article is a follows.



http://www.msaustralia.org.au/vic/ms%20 ... 0Burks.pdf


Bromley

Here's a radio broadcast from the BBC that some might find interesting: http://www.bbc.co.uk/radio4/science/other_medicine.shtml Jump to the third programme on the page for a brief discussion of CAM, placebo effect and immune systems.

Anyone got any experience of any CAM and MS?

John

PS I'm not evangelising any ...

Dear all,

This is the final presentation from the European MS conference which ended on Saturday. Could someone in the know translate it for us non-scientists. My gut feeling is that it is saying that scientists still haven't got a clue what MS is about and much more research is needed (at least this disease is keeping some people in work!).


Bromley



Closing Session
Perspective of future MS research
D.A.S. Compston (Cambridge, UK)
Invited speaker ...